Nadhir Yousfi
Overview
Explore the profile of Nadhir Yousfi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yousfi N, Mousseaux C, Hamza A, Laville P, Mille M, Philippe N, et al.
Blood
. 2024 Aug;
144(21):2266-2269.
PMID: 39197070
Using nanopore sequencing, we showed the feasibility and impact of rapid genomic screening for managing thrombotic microangiopathies in 18 prospective cases, achieving diagnoses in <3 days. We compared the results...
2.
Hamza A, El-Sissy C, Yousfi N, Vieira Martins P, Rafat C, Masliah-Planchon J, et al.
Eur J Hum Genet
. 2023 Apr;
31(7):730-732.
PMID: 37032353
No abstract available.
3.
Berchtold L, Letouze E, Alexander M, Canaud G, Logt A, Hamilton P, et al.
Kidney Int
. 2021 Jun;
100(1):243.
PMID: 34154713
No abstract available.
4.
Dembele M, Delafosse M, Yousfi N, Debiec H, Ngo K, Plaisier E, et al.
Med Sci (Paris)
. 2021 Mar;
37(3):242-248.
PMID: 33739271
In this article, we present the latest innovations to generate in vitro models of the glomerular filtration barrier. There is currently a growing interest for such model systems that allow...
5.
Berchtold L, Letouze E, Alexander M, Canaud G, Logt A, Hamilton P, et al.
Kidney Int
. 2020 Sep;
99(3):671-685.
PMID: 32889013
Recurrence of primary membranous nephropathy after transplantation occurs in up to 44% of patients and is driven by PLA2R antibody. Here, we asked whether genetic determinants could improve risk prediction....
6.
Mennetrier L, Lopez T, Pruvot B, Yousfi N, Armant O, Hazhaz H, et al.
Chronobiol Int
. 2018 Mar;
35(7):1008-1015.
PMID: 29509048
HSF1 is a transcription factor that plays a key role in circadian resetting by temperature. We have used zebrafish embryos to decipher the roles of zHsf1, heat and light on...
7.
Berthenet K, Boudesco C, Collura A, Svrcek M, Richaud S, Hammann A, et al.
Oncoimmunology
. 2016 Sep;
5(7):e1170264.
PMID: 27622020
HSP110 is induced by different stresses and, through its anti-apoptotic and chaperoning properties, helps the cells to survive these adverse situations. In colon cancers, HSP110 is abnormally abundant. We have...
8.
Lamrani M, Sassi N, Paul C, Yousfi N, Boucher J, Gauthier N, et al.
Oncoimmunology
. 2016 Jul;
5(5):e1123369.
PMID: 27467924
Toll-like receptor (TLR) 4 agonists have emerged as a new group of molecules used for cancer therapy. They have been exploited to enhance the immunogenicity of current chemotherapeutic regimens. However,...
9.
Ben Bahria-Sediki I, Yousfi N, Paul C, Chebil M, Cherif M, Zermani R, et al.
J Transl Med
. 2016 May;
14(1):144.
PMID: 27237631
Background: The aim of this study was to investigate the clinical significance of three immune cell-related transcription factors, T-bet, GATA-3 and Bcl-6 in bladder cancer in Tunisian patients. Methods: Expression...
10.
Yousfi N, Pruvot B, Lopez T, Magadoux L, Franche N, Pichon L, et al.
PLoS One
. 2015 Mar;
10(3):e0120435.
PMID: 25768009
To investigate the effect of nitric oxide on tumor development, we established a rat tumor xenograft model in zebrafish embryos. The injected tumor cells formed masses in which nitric oxide...